Stay updated on Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s footer “Revision” version was updated from v3.5.2 to v3.5.3, reflecting a backend/site release rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:50:00.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.5.2 updated from v3.5.0. No visible changes to study details or page content.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:59.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added the keyword/MeSH term 'B-cell chronic lymphocytic leukemia.' Added a new resource link to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T15:27:15.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.0, replacing v3.4.3. This is a UI/version change and does not alter study details or eligibility.
    Difference
    0.1%
    Check dated 2026-03-19T03:29:05.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T20:12:47.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Updates to the study record dates show new entries on 2026-03-02, 2026-02-26, and 2026-02 and removal of entries on 2025-12-24, 2025-12-08, and 2025-12, indicating revisions to the trial information.
    Difference
    0.2%
    Check dated 2026-03-04T15:16:18.000Z thumbnail image

Stay in the know with updates to Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.